FORMULATION AND IN-VITRO EVALUATION GASTRORETENTIVE DRUG DELIVERY OF TINIDAZOLE
Abstract
The aim of the current study was to design oral controlled release gastro-retentive drug delivery of Tinidazole. that are designed to retain in the stomach for a long time and have developed as a Local drug delivery system for better eradication of Helicobacter Pylori in peptic ulcer diseases. Tablets were prepared by direct compression and evaluated for evaluated for various physical parameters, Hardness, friability, drug Content, floating ability, Lag time, Swelling Index studies, and in vitro dissolution parameters as well as kinetics of release were assessed. Factorial design for 2 factors at 3 levels each was employed to systematically optimize drug release profile and Floating Behaviour. Sodium Alginate and Hydroxy Propyl Metheyl Celluiose (HPMC K15M) were taken as the independent variables. Response surface plots and contour plots were drawn.Compressed tablets exhibited zero order drug release kinetics, resulting in regulated and complete release until 12 hours. Polynomial mathematical models, generated for various response variables using multiple linear regression analysis, were found to be statistically significant (P < 0.05).Both the polymers had significant effect on the release profiles of the tablets, Besides unraveling the effect of the 2 factors on the various response variables, the study helped in finding the optimum Formulation ‘F4’ with Floating Lag Time (20 sec.) and having controlled release upto 12 hours (99.47%). Meanwhile, sustained profiles of drug release were also obtained. In general, these systems can float in the gastric conditions and control the drug release from the tablets.DOI
https://doi.org/10.22270/jddt.v5i2.1061Published
2015-03-13
Statistics
Abstract Display: 626
PDF Downloads: 903 How to Cite
1.
Dalvi PB, NANDAN SS, GANGURDE PR, GANGURDE SA. FORMULATION AND IN-VITRO EVALUATION GASTRORETENTIVE DRUG DELIVERY OF TINIDAZOLE. J. Drug Delivery Ther. [Internet]. 2015 Mar. 13 [cited 2026 Jan. 22];5(2):55-64. Available from: https://jddtonline.info/index.php/jddt/article/view/1061
Issue
Section
Research
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
1.
Dalvi PB, NANDAN SS, GANGURDE PR, GANGURDE SA. FORMULATION AND IN-VITRO EVALUATION GASTRORETENTIVE DRUG DELIVERY OF TINIDAZOLE. J. Drug Delivery Ther. [Internet]. 2015 Mar. 13 [cited 2026 Jan. 22];5(2):55-64. Available from: https://jddtonline.info/index.php/jddt/article/view/1061

.